Royce & Associates LP Atrion Corp Transaction History

Royce & Associates LP

$10.5 Billion
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$308.3 - $463.55 $603,034 - $906,703	-1,956 Reduced 58.16%	1,407 $652,000
Q4 2023 Feb 12, 2024	SELL	$289.29 - $409.7 $3.65 Million - $5.17 Million	-12,613 Reduced 78.95%	3,363 $1.27 Million
Q3 2023 Nov 09, 2023	BUY	$401.2 - $581.79 $4,012 - $5,817	10 Added 0.06%	15,976 $6.6 Million
Q2 2023 Aug 07, 2023	BUY	$500.0 - $659.0 $16,000 - $21,088	32 Added 0.2%	15,966 $9.03 Million
Q1 2023 May 04, 2023	SELL	$565.0 - $694.87 $4,520 - $5,558	-8 Reduced 0.05%	15,934 $10 Million
Q4 2022 May 23, 2023	BUY	$551.1 - $688.5 $4,408 - $5,508	8 Added 0.05%	15,942 $8.92 Million
Q4 2022 Feb 13, 2023	SELL	$551.1 - $688.5 $3.09 Million - $3.85 Million	-5,598 Reduced 25.99%	15,942 $8.92 Million
Q3 2022 Nov 03, 2022	BUY	$545.43 - $680.3 $12,544 - $15,646	23 Added 0.11%	21,540 $12.2 Million
Q2 2022 Aug 04, 2022	BUY	$605.0 - $763.25 $7,260 - $9,159	12 Added 0.06%	21,517 $13.5 Million
Q1 2022 May 05, 2022	SELL	$601.4 - $763.0 $6,615 - $8,393	-11 Reduced 0.05%	21,505 $15.3 Million
Q4 2021 Feb 07, 2022	BUY	$650.15 - $802.0 $13,003 - $16,040	20 Added 0.09%	21,516 $15.2 Million
Q3 2021 Nov 10, 2021	SELL	$594.24 - $758.0 $8,319 - $10,612	-14 Reduced 0.07%	21,496 $15 Million
Q2 2021 Aug 06, 2021	SELL	$582.88 - $670.99 $2,331 - $2,683	-4 Reduced 0.02%	21,510 $13.4 Million
Q1 2021 May 10, 2021	BUY	$619.2 - $736.0 $10,526 - $12,512	17 Added 0.08%	21,514 $13.8 Million
Q4 2020 Feb 08, 2021	SELL	$576.6 - $672.2 $2.07 Million - $2.41 Million	-3,583 Reduced 14.29%	21,497 $13.8 Million
Q3 2020 Nov 12, 2020	SELL	$620.1 - $689.89 $1.24 Million - $1.38 Million	-2,002 Reduced 7.39%	25,080 $15.7 Million
Q2 2020 Aug 07, 2020	SELL	$610.05 - $713.9 $4.06 Million - $4.75 Million	-6,650 Reduced 19.71%	27,082 $17.3 Million
Q1 2020 May 12, 2020	SELL	$615.5 - $751.4 $1.16 Million - $1.42 Million	-1,891 Reduced 5.31%	33,732 $21.9 Million
Q4 2019 Feb 06, 2020	SELL	$688.5 - $846.15 $81,931 - $100,691	-119 Reduced 0.33%	35,623 $26.8 Million
Q3 2019 Nov 13, 2019	SELL	$722.04 - $840.0 $129,245 - $150,360	-179 Reduced 0.5%	35,742 $27.8 Million
Q2 2019 Aug 12, 2019	SELL	$837.83 - $927.0 $144,944 - $160,371	-173 Reduced 0.48%	35,921 $30.6 Million
Q1 2019 May 09, 2019	SELL	$709.9 - $885.4 $1.19 Million - $1.49 Million	-1,682 Reduced 4.45%	36,094 $31.7 Million
Q4 2018 Feb 11, 2019	SELL	$667.94 - $785.7 $977,864 - $1.15 Million	-1,464 Reduced 3.73%	37,776 $28 Million
Q3 2018 Nov 13, 2018	BUY	$602.8 - $699.6 $7,836 - $9,094	13 Added 0.03%	39,240 $27.3 Million
Q2 2018 Aug 09, 2018	BUY	$568.25 - $635.8 $101,148 - $113,172	178 Added 0.46%	39,227 $23.5 Million
Q4 2017 Feb 09, 2018	SELL	$620.6 - $689.35 $800,574 - $889,261	-1,290 Reduced 3.2%	39,049 $24.6 Million
Q3 2017 Nov 13, 2017	SELL	$608.7 - $680.0 $465,046 - $519,520	-764 Reduced 1.86%	40,339 $27.1 Million
Q2 2017 Aug 07, 2017	BUY	N/A	41,103	41,103 $26.4 Million

Others Institutions Holding ATRI

# of Institutions

Shares Held

114K

Call Options Held

Put Options Held

View Full List

About ATRION CORP

Ticker ATRI
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 1,785,990
Description
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in vari...

More about ATRI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.

Account